Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
|Webcasts|November 16, 2022
The Importance of IRT in the Decentralized Clinical Trial Landscape
Author(s)YPrime
Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Interactive Response Technology (IRT) plays an increasingly significant role in addressing the complex challenges of drug management and distribution for decentralized and hybrid clinical trials. Register for this webinar to learn more about how this technology can be used more effectively to enable patient-centric clinical trials.
Register Free:
Event Overview:
Patient-centric clinical trials such as decentralized or hybrid clinical trials can create complex challenges for drug management and distribution. Interactive Response Technology (IRT) plays an increasingly significant role in delivering an efficient and streamlined experience for patients, sites, and sponsors. Understanding how this technology can be used more effectively to deliver a better experience while minimizing risks to clinical trials will be one key to the successful adoption of decentralized and hybrid clinical trials.
Key Learning Objectives
By the end of this webinar, attendees will be able to:
- List some of the major challenges the DCT or hybrid model can create for drug management and distribution
- Discuss how IRT can be used effectively in DCTs
- Examine how the industry can work collaboratively to improve how this technology enables DCTs and hybrid trials
Who Should Attend
- Company Type:
- Emerging Bio
- Small and Mid-sized Pharma
- Large Pharma
- Other (CRO—small, mid, and large)
- Titles
- Directors and VPs of clinical development, clinical research, R&D, IRT, IT
- Managers of clinical development, clinical research, R&D, IRT, IT
Speaker
Jon Paras
Strategic Solutions
YPrime
Jon Paras is Vice President of Strategic Solutions for YPrime. An industry-recognized IRT subject matter expert, Jon has more than twenty years of experience in IRT software testing, project management, business analysis/software design, business process efficiency, and clinical supply chain / IRT synergy. He collaborates with biopharmaceutical companies on the appropriate application of IRT design based on clinical protocol and sponsor business process.
Register Free:
Related to this article
Clinical trial endpoints define what success looks like, but patients and caregivers are rarely the ones setting that definition, and the gap between what trials measure and what patients actually value is showing up in post-approval evidence, regulatory submissions, and the design rooms where protocols are written.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects on its future potential, where enrollment predictability may be the biggest prize of all.
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5